A Safety and Efficacy Study of LYS-GM101 Gene Therapy in Patients With GM1 Gangliosidosis
Condition(s):GM1 GangliosidosisLast Updated:September 2, 2022Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):GM1 GangliosidosisLast Updated:September 2, 2022Active, not recruiting
Condition(s):Ventilator Associated Pneumonia; Prevention; Respiratory Infection OtherLast Updated:July 1, 2021Terminated
Condition(s):HealthyLast Updated:February 21, 2023Completed
Condition(s):Healthy; Type 2 Diabetes MellitusLast Updated:October 12, 2017Terminated
Condition(s):HypertensionLast Updated:July 12, 2017Withdrawn
Condition(s):Scorpion Stings; Pain; AnalgesicLast Updated:July 30, 2019Completed
Condition(s):Healthy SubjectsLast Updated:February 9, 2023Active, not recruiting
Condition(s):Low Back PainLast Updated:March 8, 2012Unknown status
Condition(s):Physiologically Healthy Adult Male ParticipantsLast Updated:July 18, 2017Unknown status
Condition(s):Cystic FibrosisLast Updated:July 31, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.